跳至主要内容
临床试验/ISRCTN13088814
ISRCTN13088814已完成未知

To compare ticagrelor monotherapy following ticagrelor dual antiplatelet therapy (DAPT) (ticagrelor + aspirin) with clopidogrel DAPT (clopidogrel + aspirin) in elderly patients with unstable angina pectoris after elective percutaneous coronary intervention

First People's Hospital of Taicang0 个研究点目标入组 196 人开始时间: 2021年4月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
196

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Elderly UAP patients admitted to the Department of Cardiology of Taicang Hospital affiliated to Suzhou University (Taicang First People's Hospital) from May 2018 to May 2020
  • 2. Successfully underwent an elective PCI operation with no complications during the perioperative period
  • 3. Patients informed and agreed to participate in the study before and after inclusion

排除标准

  • 1. Fatal or persistent bleeding diseases in the past 3 months
  • 2. Severe liver and kidney insufficiency
  • 3. New York Heart Association (NYHA) class III-IV heart failure
  • 4. Patients who could not tolerate antiplatelet drug therapy
  • 5. Patients who did not comply with the treatment regimen

研究者

发起方
First People's Hospital of Taicang

相似试验

Effect of ticagrelor versus clopidogrel plus aspirin... | 临床试验